
Glioblastoma is a malignant neoplasm that arises from glial cells of the brain. The tumor is heterogeneous and requires a differentiated therapeutic approach. When elaborating a treatment regimen, German oncologists take into account the molecular and genetic composition of the tumor and its location in relation to vital parts of the brain.

Standard therapy for glioblastoma includes surgical removal of the tumor in combination with chemotherapy or radiation therapy. With standard treatment, the average life expectancy after diagnosing the pathology is 15-17 months, and the 5-year survival rate does not exceed 3-5%. Supplementing the standard protocol with the dendritic...

Cancer is one of the most common causes of human deaths, along with cardiovascular pathologies. A complete cure or effective treatment has not been developed yet. Moreover, traditional therapy may not bring results to its advanced stage, so patients simply receive symptomatic treatment.

Immunotherapy represents a groundbreaking approach to cancer treatment, with dendritic cell therapy emerging as one of its most promising innovations. This revolutionary method harnesses the power of the patient's own immune system to fight malignant tumors. The significance of dendritic cells in cancer treatment was recognized with...

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Medicine awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment protocols.

Sarcoma represents a group of malignant tumors that develop in soft and hard connective tissues, characterized by aggressive spread and early metastasis. Following the Nobel Prize-winning discovery of dendritic cells, sarcoma cancer treatment in Germany has achieved the highest European survival rates by combining traditional...

A few decades ago a diagnosis of “cancer” sounded like a death sentence. Today, many oncologic diseases can be successfully cured thanks to the rapid development of healthcare. Medical science in prosperous countries such as Germany has succeeded in increasing the rate of curing these diseases.

Treatment of colon cancer with dendritic cells (DC) is one of the modern immunotherapy types. This is an opportunity to completely get rid of cancer or control the disease for a long time at an advanced stage. The monumental importance of this approach was recognized by the Nobel Committee when they awarded the 2011 Nobel Prize in Medicine...